3-BROMO-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRIDINE, 95.0%, 1g

2-(O-tolyl)-1H-benzo[d]imidazole, 95.0%, 1g

2,2-Bis(3-nitrophenyl)hexafluoropropane>97.0%(GC)5g

Ethyl 6-formylpyridine-2-carboxylate, 95.0%, 250mg

Methyl 2-(chlorosulfonyl)-4-fluorobenzoate, 97%, 5g

4-(1,1-Dioxo-1lambda*6*-[1,2]thiazinan-2-yl)-benzoic acid, 250mg

Sal sódica de D-luciferina, mín. 99 %, para bioquímica, 10 mg, envase de vidrio

3,4,5-Trifluorocinnamic acid, 97.0%, 1g

2-(2-METHYLPROPYL)PYRROLIDINE HCL, 95.0%, 1g

(2E)-1-(4-bromophenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

1-Methyl-1H-benzimidazole-5-carboxylic acid, 95.0%, 5g

6-BROMO-8-METHOXY-[1,2,4]TRIAZOLO[1,5-A]PYRAZINE, 95%, 1g

2-Methyl-4-nitrophenol, 95.0%, 500g